Regeneron, US75886F1075

Regeneron stock at USD 788.04 on September 25, 2026, down 1.00 percent

Published on 09/28/2026 at 08:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Regeneron stock last traded at USD 788.04 on September 25, 2026, down 1.00 percent. The company has scheduled its third-quarter 2026 results for October 30.

Fotorealistisches Biotech-Labor mit Forschern und Pipetten an sterilen Arbeitsplätzen
Regeneron Pharma US75886F1075 zeigt ein fotorealistisches Biotech-Labor mit Forschern bei sorgfältigen Pipettierarbeiten am sterilen Steriltisch, Illustration mit AI erstellt.

Regeneron Pharmaceuticals, Inc. shares last traded at USD 788.04 on Nasdaq on September 25, 2026, down 1.00 percent from the previous session.

Third-quarter reporting date

Regeneron Pharmaceuticals, Inc. announced on September 24, 2026, that it will report its third-quarter 2026 financial and operating results on Friday, October 30, before U.S. financial markets open.

Conference call scheduled

The company said it will host a conference call and simultaneous webcast at 8:30 AM Eastern Time on October 30. The webcast will be available through Regeneron's investor website, and the company said a replay and transcript will be archived for at least 30 days.

Disclaimer...

en | US75886F1075 | REGENERON | boerse | 70191234 | bgmi